Urgent.News

600+ sources. One page. See who else covered it.

Editions

Finance & Markets

Stocks to watch: CICT, Frasers Property, CLI, YZJ Maritime, Singapore Land, Ambiq Micro, Digital Core Reit, MetaOptics

[SINGAPORE] The following companies saw new developments that may affect trading of their securities on Wednesday (Aug 12):

CapitaLand Integrated Commercial Trust (CICT) reported a higher distribution per unit (DPU) of S$0.0602 for its first half ended June 30, representing a 7.1% increase year-on-year. This growth was driven by improved operating performance and reduced interest expenses, despite an increased unit base following a private placement in April.

The DPU growth resulted in a 13.3% rise in distributable income to S$466.7 million, while net property income increased by 8.7% to S$630.5 million. CICT's shares rose by 2%, closing S$0.05 higher at S$2.51 on Tuesday.

Frasers Property announced that it will seek shareholder approval to optimize the portfolio of Frasers Hospitality Trust during an extraordinary general meeting on August 28. This move is part of the group's strategy to unlock capital from stabilized assets and refine its hospitality approach. The company's unrecognised residential revenue across Singapore, Australia, Thailand, and China stood at approximately S$1 billion as of end-June, a decline from S$1.4 billion a year earlier. Frasers Property's shares remained unchanged at S$1.05 prior to the news.

Written by urgent.news from The Business Times - Companies & Markets's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at businesstimes.com.sg →

More in Finance & Markets

Celltrion Expands Market Presence in Spain and Portugal Through Tender Wins

Celltrion is rapidly strengthening its presence in Spain and Portugal, securing a series of government and regional tenders while expanding sales and marketing activities to drive prescriptions and…

  • Celltrion wins government tenders in Spain and Portugal, expanding market presence.
  • Omlyclo biosimilar dominates Spanish market with 90% share by June.
  • Actemra and other biosimilars gain significant market share in Spain and Portugal.

More from Wednesday 12 August →